Clinical Trials Browser

Phase 2 × Withdrawn × thymoglobulin × Clear all

NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Phase 2 Withdrawn

Neuroblastoma, Recurrence